杰诺维DPP-4抑制剂的同与异课件.pptVIP

We included studies in this meta-analysis if (1) they were RCTs comparing DPP4 inhibitor monotherapy in 1 arm to other oral antitype 2 DM agents (other than DPP4 inhibitors) in the comparator arm, (2) duration of treatment was 24 weeks, and (3) reported data on adverse CV side effects of DPP4 inhibitor therapy (death from CV causes, nonfatal myocardial infarction or acute coronary syndrome, stroke, heart failure, and arrhythmias).The quality of included articles was further assessed。 The primary end point was development of adverse CV events defined as death from CV causes, nonfatal myocardia